Monty Krieger

This inventor holds 15 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Massachusetts Institute of Technology, The Broad Institute, Inc., University of Pennsylvania. Active years: 1996-2018.

USPTO Granted Patents = 15 (Patent Applications = 3)

% Patents Active = 86.7

EPO Patents = 1

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 111(Granted Patents)

Company Filing History:

14 out of 8,576

Massachusetts Institute of Technology

patents

2 out of 482

The Broad Institute, Inc.

patents

2 out of 2,651

University of Pennsylvania

patents

4. 1 out of 5,630

The University of Texas System

6. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2018

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9951055 - Thiazole-based inhibitors of scavenger receptor BI (2018-04-24),

2. 9884851 - Heterocycle-bisamide inhibitors of scavenger receptor BI (2018-02-06),

3. 9603897 - Methods for treating tissue damage associated with ischemia with apolipoprotein D (2017-03-28),

4. 7514592 - Inducible heart attack animal model (2009-04-07),

5. 7361684 - Screening of compounds for treatment of atherosclerosis and heart attack (2008-04-22),

6. 7208467 - Lipid-altering compositions for the treatment of infertility (2007-04-24),

7. 7078511 - Class BI and CI scavenger receptors (2006-07-18),

8. 6962688 - Methods for modulation of cholesterol transport (2005-11-08),

9. 6437215 - SR-BI and ApoE knockout animals and use thereof as models for atherosclerosis and heart attack (2002-08-20),

10. 6429289 - Class BI and CI scavenger receptors (2002-08-06),

11. 6350859 - Class BI and CI scavenger receptors (2002-02-26),

12. 5962322 - Methods for modulation of cholesterol transport (1999-10-05),

13. 5925333 - Methods for modulation of lipid uptake (1999-07-20),

14. 5624904 - Method for treating gram positive septicemia (1997-04-29),

15. 5510466 - Scavenger receptor protein and antibody thereto (1996-04-23),

Title: Monty Krieger: Innovator in Scavenger Receptor Research

Introduction

Monty Krieger is a prominent inventor based in Needham, MA (US), known for his significant contributions to the field of biochemistry and pharmacology. He holds a total of 15 patents, showcasing his innovative approach to medical research and drug development.

Latest Patents

Krieger's latest patents include groundbreaking work on thiazole-based inhibitors of scavenger receptor BI. This application describes compounds and methods that can inhibit Scavenger receptor class B, type I (SR-BI) activity. These compounds and methods can be utilized to mediate high-density lipoprotein (HDL) lipid uptake and treat hepatitis C viral infections. Another notable patent is for heterocycle-bisamide inhibitors of scavenger receptor BI, which also focuses on inhibiting SR-BI activity for similar therapeutic applications.

Career Highlights

Throughout his career, Monty Krieger has worked with prestigious institutions such as the Massachusetts Institute of Technology and the University of Pennsylvania. His research has significantly advanced the understanding of lipid metabolism and its implications for various diseases.

Collaborations

Krieger has collaborated with notable colleagues, including Attilio Rigotti and Susan Laurene Acton, contributing to a rich exchange of ideas and research findings in the field.

Conclusion

Monty Krieger's innovative work in the development of scavenger receptor inhibitors has the potential to impact the treatment of significant health issues, particularly hepatitis C. His contributions to science and medicine continue to inspire future research and innovation.